cefuroxime has been researched along with Obesity in 2 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sommerstein, R | 1 |
| Atkinson, A | 1 |
| Kuster, SP | 1 |
| Vuichard-Gysin, D | 1 |
| Harbarth, S | 1 |
| Troillet, N | 1 |
| Widmer, AF | 1 |
| Trick, WE | 1 |
| Scheckler, WE | 1 |
| Tokars, JI | 1 |
| Jones, KC | 1 |
| Reppen, ML | 1 |
| Smith, EM | 1 |
| Jarvis, WR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Controlled, Phase 4 Study of Sternal Plating (Rapid Sternal Closure System, KLS Martin L.P.) in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Complications.[NCT00638014] | Phase 4 | 51 participants (Actual) | Interventional | 2008-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Data and Safety Monitoring Board reviewed source documents for all cases with possible sternal wound infection and sternal instability or non-union and made a determination as to the presence of these complications. (NCT00638014)
Timeframe: Up to 180 days
| Intervention | Participants (Number) |
|---|---|
| Conventional Wires Only | 1 |
| Talon | 1 |
Maximum incentive spirometry volume was measured at baseline (prior to surgery) and daily from postoperative day 1 through postoperative day 7 (or discharge if earlier) using a Coach 2 incentive spirometer with one way valve (Coach 2 model # 22-4000, Smiths Medical, Keene, NH). (NCT00638014)
Timeframe: Baseline, Maximum value during postoperatively days 1 thru 7
| Intervention | percentage change (Mean) |
|---|---|
| Conventional Wires Only | 58 |
| Talon | 67 |
2 other studies available for cefuroxime and Obesity
| Article | Year |
|---|---|
Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Weig | 2021 |
Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting.
Topics: Aged; Case-Control Studies; Cefuroxime; Cephalosporins; Chi-Square Distribution; Coronary Artery Byp | 2000 |